About Barricaid
Barricaid is a Healthcare company based in Woburn (United States) founded in 2006 by Jacob Einhorn. It operates as an annular closure implants are provided for lumbar disc herniation treatment. Barricaid has raised $197.12 million across 6 funding rounds from investors including Greenspring Associates, Questa Capital and NEA. Its chief executive is Keith Valentine. Its website barricaid.com draws about 24 thousand monthly visits. Barricaid offers products and services including Barricaid Implant. Its focus areas include Life Sciences, Orthopedics, Medical Devices and Therapies. Its legal entity is Authentidate Holding Corp. Its competitors include Spinol.
Company details
Barricaid was founded in 2006 and is based in Woburn, United States, within the medical device sector focused on spinal treatments. Annular closure implants are offered for primary discectomy patients with large defects in lumbar discs. The system incorporates occlusion and anchor components. Level-I clinical data demonstrate reductions of 52 in symptomatic recurrent herniations and 61 in reoperations for this group.
- Total Equity Funding$197.12M (USD)
in 6 rounds
- Latest Funding Round$55.49M (USD), Series E
Nov 2023
- InvestorsGreenspring Associates
& 4 more
Products & Services of Barricaid
Barricaid offers a comprehensive portfolio of products and services, including Barricaid Implant.
Implant to reduce reherniation after discectomy surgery
Apps and channels of Barricaid
its YouTube channel Barricaid® has 409 subscribers and 30 videos.
Videos from Barricaid
The most watched videos on Barricaid's YouTube channel, Barricaid® (409 subscribers). Click a video to play it here.
More on Barricaid®.
Funding Insights of Barricaid
Barricaid has successfully raised a total of $197.12M across 6 strategic funding rounds. The most recent funding activity was a Series E round of $55.49 million completed in November 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $197.12M
- Total Rounds 6
- Last Round Series E — $55.49M
- First Round $17.26M
(Sep 2014)
- Investors Count 5
All 6 funding rounds of Barricaid with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov 2023 | $55.49M | Series E | – | – | – |
| Aug 2023 | $5.5M | Series E | – | – | – |
| Apr 2021 | $38.44M | Series E | – | – | – |
| Apr 2019 | $52M | Series E | – | Questa Capital | |
| Mar 2017 | $28.43M | Series D | – | – | – |
| Sep 2014 | $17.26M | Series C | – | – | – |
5 investors in total: 5 institutional.
Investors in Barricaid
Barricaid has secured backing from 5 investors, including venture fund investors. Prominent investors backing the company include Greenspring Associates, Questa Capital and NEA.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Growth-stage VC and PE investments are directed across multiple sectors. | – | questacapital.com | San Francisco, United States | |
Venture capital investments are offered to startups by NEA. | – | nea.com | Menlo Park, United States | |
Diversified investment management firm | 2000 | greenspringassociates.com | Owings Mills, United States | |
Sector-agnostic investment company making venture capital investments globally | – | quadrillecapital.com | Paris, France | |
Delos Capital is engaged in private equity and financial advisory services. | – | deloscap.com | New York City, United States |
Investor details for Barricaid
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Barricaid
48 people are tracked at Barricaid (20 in leadership, 4 in board & advisors, 24 in team).
| Name | Role | Group |
|---|---|---|
Jacob Einhorn | Co-Founder & Chief Technology Officer | Leadership |
Keith Valentine | Co-CEO | Leadership |
Cary Hagan | Co-CEO & President | Leadership |
Kelsey Miller-Torchia | VP, Clinical Affairs | Leadership |
Oscar C. Yeh | Chief Operating Officer | Leadership |
Jake Tanner | VP, Marketing | Leadership |
Jason Brosniak | Area Vice President, Sales | Leadership |
Jean Fraser | Director Patient Access | Leadership |
Bryan Romney Larsen | Director Of Sales Training | Leadership |
Ivan Grzan | Senior Director, Professional Education | Leadership |
Diana Seymour | National Director Of Market Development | Leadership |
Peter Pizzo | Chief Financial Officer | Leadership |
Detlev Lieberz | Associate Director Clinical Affairs | Leadership |
John Insley | Area Vice President - West | Leadership |
Glenn Sanders | Vice President, R&d And Manufacturing | Leadership |
Ralph Beentjes | VP, Customer Relations & Sales Operations | Leadership |
Kyriacos Spentzos | Vice President Academic & Distribution Development | Leadership |
Ashley Ladd | Area Vice President | Leadership |
Nick Grow | Director Of Quality Assurance | Leadership |
Joe Anderson | Area Vice President | Leadership |
28 more people are available in the full profile.
Complete people profiles for Barricaid
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Barricaid
3 dated milestones of Barricaid across 17 years, from founding to its latest funding, stage changes and deals.
- Founded Barricaid is founded.
- Funding First funding round of $17.3M.
- Funding Latest funding round, Series E, of $55.5M.
Competitors of Barricaid
Barricaid has 1 listed competitor in our database. They include Spinol, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| spinolmedical.com | 2018 | – | – | – | Develops innovative implants to seal disc ruptures after spinal surgery procedures. |
Detailed competitors of Barricaid
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Barricaid
The website of Barricaid (barricaid.com) receives about 24.3K visits a month.
- Monthly visits24.3K
▲ 11% vs previous month
Websites whose visitors overlap most with Barricaid. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
doneurosurgery.com | doneurosurgery.com | 100% | – | #1,774,691 | – |
newyorkspinespecialist.com | newyorkspinespecialist.com | 92% | – | #743,414 | – |
coreconceptsphysio.sg | coreconceptsphysio.sg | 91% | – | #551,723 | – |
laspine.com | laspine.com | 87% | – | #2,785,759 | – |
easyposturebrands.com | easyposturebrands.com | 79% | – | #4,214,958 | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 32 similar websites and full traffic analytics for Barricaid
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 32 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Orthopedics
10 companies that operate in the same segment as Barricaid (Orthopedics), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Provider of high-frequency spinal cord stimulation implants | 2006 | Menlo Park, California, United States | USD 154.1 M | USD 353.08 M | 1,215 | |
Prosthetic and orthotic devices are developed for individuals with disabilities. | 1919 | Duderstadt, Lower Saxony, Germany | USD 17 M | USD 1.97 B | 4,125 | |
Developer of therapies for the treatment of musculoskeletal disorders | 2007 | Woburn, Massachusetts, United States | USD 62 M | USD 85.55 M | 692 | |
Developer of drugs for treating rare and autoimmune diseases | 2008 | Dublin, Ireland | USD 61.78 M | USD 617.41 M | – | |
Antibody-siRNA complexes are developed for cancer treatment. | 2012 | San Diego, California, United States | USD 142.54 M | USD 10.9 M | 391 | |
Smart surgical devices for spinal surgery are developed. | 1997 | San Diego, California, United States | USD 54.1 M | – | – | |
Robotic arms are provided for mobility and rehabilitation support. | 2004 | Boston, Massachusetts, United States | USD 17.21 M | USD 40.93 M | 185 | |
AI-powered drug discovery platform for various diseases | 2016 | New York, New York, United States | USD 608.25 M | – | 197 | |
Exoskeletons for medical rehabilitation and industrial productivity are provided. | 2005 | United States | USD 24.37 M | USD 71.6 M | 61 | |
Stabilization devices for healthcare are manufactured by the company. | 2005 | New York, New York, United States | USD 142.15 M | – | 43 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Barricaid
Complete news archive for Barricaid
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Barricaid
Barricaid was founded in 2006 and raised its 1st funding round 8 years after it was founded.
Barricaid is headquartered in Woburn, United States. It is registered at Woburn, Massachusetts, United States.
Keith Valentine is the current CEO of Barricaid.
Barricaid is a funded company, having raised a total of $197.12M across 6 funding rounds to date. The company's 1st funding round was a Series C of $17.26M, raised on Sep 2014.
Barricaid was founded in 2006 and is based in Woburn, United States, within the medical device sector focused on spinal treatments. Annular closure implants are offered for primary discectomy patients with large defects in lumbar discs. The system incorporates occlusion and anchor components. Level-I clinical data demonstrate reductions of 52 in symptomatic recurrent herniations and 61 in reoperations for this group.
Barricaid's top competitors include Spinol.
Barricaid offers Barricaid Implant.
Barricaid has 5 investors. Key investors include Greenspring Associates, Questa Capital, NEA, Quadrille Capital, and Delos Capital.
Barricaid operates through Authentidate Holding Corp.